Status: current, Primitive. Date: 31-Jan 2017. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3316117017 | Atezolizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3316118010 | Atezolizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Atezolizumab | Is a | Programmed cell death protein 1 inhibitor | true | Inferred relationship | Some | ||
| Atezolizumab | Has disposition | Programmed cell death protein 1 inhibitor | true | Inferred relationship | Some | ||
| Atezolizumab | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Atezolizumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Atezolizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Atezolizumab only product | Has active ingredient | True | Atezolizumab | Inferred relationship | Some | 1 |
| Atezolizumab only product in parenteral dose form | Has active ingredient | True | Atezolizumab | Inferred relationship | Some | 1 |
| Atezolizumab-containing product | Has active ingredient | True | Atezolizumab | Inferred relationship | Some | 1 |
| Atezolizumab-containing product in parenteral dose form | Has active ingredient | True | Atezolizumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR